Pharma Reviews: India's Stelis Biopharma to make 200 million doses of Sputnik V vaccine

Stelis' pact with the Russian Direct Investment Fund (RDIF) follows similar deals struck by Indian pharmaceutical firms Gland Pharma and Hetero to ...
Read more: India's Stelis Biopharma to make 200 million doses of Sputnik V vaccine